Enable Injections wins CE mark for enFuse drug delivery device

Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery.

enFuse, an on-body delivery system, provides subcutaneous abdominal bolus administration of drug or biologic products in accordance with the drug product requirements. The mechanical, wearable device can deliver large volumes of small molecule and biologic medications subcutaneously. Patients can receive their needed treatment in a single injection under the skin, rather than the intravenous route.

Enable Injections designed enFuse to streamline and improve in-clinic or patient self-administration. enFuse features hands-free, hidden needle drug delivery.

Sign up for Blog Updates